Abstract:INTRODUCTIONLow vitamin D levels have been associated with type 2 diabetes mellitus and non-alcoholic fatty liver disease. Insulin resistance, inflammation and oxidative stress have been suggested to be responsible for the development of NAFLD. These mechanisms are linked to vitamin D’s anti-inflammatory effect. Vitamin D deficiency is highly prevalent among patients with T2DM and NAFLD and is an independent risk factor for developing NAFLD in patients with T2DM. METHODOLOGYThe study aimed to determine the prevalence and associated risk factors of vitamin D deficiency in patients with NAFLD and T2DM. We conducted a cross-sectional study in patients with T2DM (n=110). The patients were divided into 2 groups: NAFLD (n=86) and no NAFLD (n = 24). The patients within the NAFLD group were further divided into 2 groups (vitamin D deficient and non-deficient). Serum total 25 (OH) D3 was analysed using electrochemiluminescence immunoassay (Roche), and deficiency was defined as a level of <50 nmol/L. Diagnosis of NAFLD was based on the abdominal ultrasound performed by 2 experienced radiologists. Steatosis was defined as increased liver echogenicity. RESULTThe prevalence of vitamin D deficiency in patients with T2DM and NAFLD was 52.3% (45/86), as compared to only 33.8% (8/24) in those without NAFLD. Vitamin D level was significantly lower in patients with NAFLD as compared to those without NAFLD (51.53 ± 19.68 vs 60.61 ± 20.25, p <0.05). There was no difference in the age (57.74 ± 8.42 vs 57.96 ± 7.97 years, p = 0.91), gender (male 55.7% vs 70.8%, p = 0.18), BMI (28.99 ± 3.80 vs 28.24 ± 3.74 kg/m2 , p = 0.40), and diabetes duration (12.43 ± 7.92 vs 10.42 ± 6.51, p = 0.25), between the 2 groups. Multivariate analysis demonstrated that HbA1c (AOR 1.89; 95%CI 1.15-3.09; p = 0.01) and vitamin D deficiency were the independent risk factors for NAFLD (AOR 3.15 95%CI 1.10-9.04; p = 0.03), after adjustment for age, gender, diabetes duration and eGFR. CONCLUSIONThis study demonstrated a high prevalence of vitamin D Deficiency in patients with NAFLD and T2DM. In patients with T2DM, those with vitamin D deficiency were three times more likely to develop NAFLD. Vitamin D levels of <50 nmol/L and higher HbA1c were the two independent risk factors for developing NAFLD.

The serum vitamin D level is inversely correlated with nonalcoholic fatty liver disease

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Inverse Association between Serum 25-hydroxyvitamin D Levels and Risk of Suspected Non-Alcoholic Fatty Liver Disease in Obese Population

The Association Between Serum Vitamin D Level and Nonalcoholic Fatty Liver Disease

Serum Vitamin D Level in Overweight Individuals and Its Correlation With the Incidence of Non-alcoholic Fatty Liver Disease

Serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study

Serum Fetuin A Level is Associated with Nonalcoholic Fatty Liver Disease in Chinese Population

Serum vitamin D is associated with ultrasound-defined hepatic fibrosis

Association of 25-Hydroxyvitamin D with Liver Cancer Incidence and Chronic Liver Disease Mortality in Finnish Male Smokers of the ATBC Study.

Serum Sialic Acid Level Is Significantly Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: A Cross-Sectional Study

Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: the Shanghai Changfeng Study.

Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study

Meta-analysis: vitamin D and non-alcoholic fatty liver disease

No Significant Association Between Vitamin D and Nonalcoholic Fatty Liver Disease in a Chinese Population

Relationship Between Vitamin D Deficiency and Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study From a Tertiary Care Center in Northern India

The Level of Vitamin D in Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Meta-Analysis

Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis

Vitamin D Receptor Targets Hepatocyte Nuclear Factor 4α and Mediates Protective Effects of Vitamin D in Nonalcoholic Fatty Liver Disease.

VITAMIN D DEFICIENCY IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS

Association and interaction between vitamin D level and metabolic syndrome for non-alcoholic fatty liver disease

Vitamin D Levels in Non-alcoholic Fatty Liver Disease in Type II Diabetic and Non-Diabetic Patients